Cardioneuroablation For the Treatment of Reflex Syncope and Functional Bradyarrhythmias: What We Learned From the EHRA/HRS/LAHRS Document (Joint Session) (non-ACE)

Description

Nowadays, there is a sharp rise in cardioneuroablation procedures although there is a lack of large randomized controlled trials and long-term follow-up.

In this joint session, the audience will get a chance to learn and interpret available evidence for anatomical nomenclature of intrinsic cardiac autonomic nervous system, patient selection for cardioneuroablation, optimal cardioneuroablation strategies, and long-term consequences of cardioneuroablation by document writers.

A joint session with EHRA/HRS/LAHRS Scientific Statement Document.

Learning Objectives

Describe the optimal patients that would benefit from cardioneuroablation.
Discuss short and long-term risks of cardioneuroablation.
Compare ganglion plexus ablation strategies for cardioneuroablation.

Session Chair(s)

Jodie Hurwitz, MD
Arshneel Kochar, MD

Presentation

Anatomy and Physiology of Cardiac Autonomic Nervous System for Cardioneuroablation
Presenter(s): Marmar Vaseghi, MD, MS, PhD

Is Cardioneuroablation Ready for Prime Time? What Does the Clinical Evidence Say?
Presenter(s): JC C. Pachon-M, MD, PhD

(Recorded Case) Approach to Cardioneuroablation for Functional AV block
Presenter(s): Carlos A. Morillo, MD

Known and Possible Risks of Cardioneuroablation
Presenter(s): Dan Wichterle, MD, PhD

Disclosures

Marmar Vaseghi:

Zoll Inc. (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Medtronic,Inc. (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
NeuCures (Stocks – Privately Held - Minor share holder)
Anumana Inc. (Stocks – Privately Held - Stockholder)

JC Pachon-M:

Personalis (Ownership/Partnership/Principal - Ownership)

Carlos Morillo:

Medtronic (Honoraria/Speaking/Consulting Fee - Consulting)
Abbott (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Novartis (Honoraria/Speaking/Consulting Fee - Membership on Advisory Committees or Review Panels)
Boston Scientific (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Kardium (Chair DSMB - Chair DSMB)

Dan Wichterle:

Nothing Relevant to Disclose

To view all Heart Rhythm 2025 Faculty Disclosures, please click here.

Education Framework

Other Arrhythmia Syndromes
-- Syncope and Autonomic Dysfunction
-- 285. Know how to treat vasovagal syncope, including lifestyle modifications, maneuvers, medications and pacing (for profound cardioinhibitory responses).

Summary


Availability:	No future session


Cost:	FREE


Credit Offered:	No Credit Offered

Recommended

Abstract Catalog 2025: ePosters

FREE